LIU, T.; Yao, J.; Abdi-Sargezeh, B.; Sharma, A.; Lasbareilles, C.; Tsi Lok Ho, R.; Cheung, J.; Denison, T.; Tan, H.; Neumann, W.-J.; Zhu, M. M.; Liu, S.; Starr, P.; Little, S.; Oswal, A.

Adaptive deep brain stimulation (aDBS) relies on physiological biomarkers to infer motor state and guide therapeutic stimulation in Parkinson's disease. However, neural biomarkers may themselves be altered by stimulation, potentially limiting their utility for closed-loop control. We address this limitation by testing whether DBS device-embedded accelerometers can accurately track Parkinsonian motor state across stimulation conditions. We analysed over 1,900 hours of chronic recordings of subthalamic nucleus (STN), sensorimotor cortical and device-embedded accelerometry signals acquired before and during continuous STN stimulation, alongside continuous wearable assessments of bradykinesia and dyskinesia. Across stimulation conditions, accelerometry-derived features robustly tracked motor symptom severity and outperformed neural features for symptom decoding. Mechanistically, total STN beta power - a widely used biomarker for aDBS - proved less informative because it conflates periodic and aperiodic neural processes with opposing relationships to motor state. Under active stimulation, periodic beta activity showed reduced coupling to symptom severity, whereas STN aperiodic activity, cortical periodic activity and cortico-subthalamic coherence remained comparatively stable. Together, these findings demonstrate that neural and behavioural biomarkers exhibit differential robustness during deep brain stimulation and identify device-embedded accelerometry as a robust behavioural biomarker of motor state, motivating its use in next-generation adaptive DBS systems.